Advertisement
New Zealand markets open in 3 hours 30 minutes
  • NZX 50

    11,803.28
    -49.52 (-0.42%)
     
  • NZD/USD

    0.5944
    +0.0023 (+0.39%)
     
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • OIL

    83.40
    +1.50 (+1.83%)
     
  • GOLD

    2,342.40
    -4.00 (-0.17%)
     

A Look at Teva Pharmaceutical’s Valuation Multiples in June

A Look at Teva Pharmaceutical’s Valuation Multiples in June

On June 13, Teva Pharmaceutical Industries (TEVA) was trading at a forward PE (price-to-earnings) ratio of 8.8x, compared to the industry average PE of 12.3x. The company’s forward EV-to-EBITDA, which is a capital structure–neutral valuation measure, is 11.2x. This multiple is higher than the industry average of 10.3x.